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Abstract 
 
Background: The etiology of Alcohol Dependence is multifactorial, resulting from the 
interplay of environmental and genetic factors, including variants in neurotransmission 
related genes. In this sense, the Soluble NSF-Attachment Protein Receptors (SNARE) 
complex, which acts on neurotransmitter release, could play an important role in this 
disorder. The aim of the present study was to evaluate polymorphisms in SNARE complex 
genes (STX1A rs2228607; SYT1 rs1880867 and rs2251214; VAMP2 26 bp Ins/Del; SNAP25 
rs6108461 and rs8636) in relation to Alcohol Dependence susceptibility.  
Methods: The sample comprised 115 men under inpatient treatment for with Alcohol 
Dependence and 308 non-dependent controls. Additionally, 278 men with Attention-
Deficit/Hyperactivity Disorder (ADHD), of which 35 presented comorbidity with Alcohol 
Dependence were subsequently evaluated in order to replicate the association.  
Results: A nominal association was found between the VAMP2 26 bp Ins/Del 
polymorphism and susceptibility to Alcohol Dependence, where the Ins/Ins genotype 
showed a risk to this disorder (p = 0.012; OR = 2.21). This result was supported by the 
ADHD replication sample, where the Ins/Ins genotype was also more frequent among 
Alcohol Dependent cases (p = 0.008; OR = 5.26). Other polymorphisms and haplotype 
analyses did not reveal significant differences between cases and controls.  
Conclusion: Overall, the present study suggests that VAMP2 26 bp Ins/Del polymorphism, 
previously associated with ADHD, is also implicated in Alcohol Dependence susceptibility. 
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1. Introduction 
 
 Alcohol Dependence (AD) is the most severe phenotype within Alcohol Use 
Disorders, being characterized by a set of symptoms that includes withdrawal, tolerance to 
alcohol and craving (DSM-IV, APA, 1994). The prevalence of AD in Brazil is estimated in 
10.48% in men and 3.63% in women (Laranjeira, 2012). The high incidence of this 
phenotype impacts substantially in social and economic areas, and represents an important 
health problem, with estimates from the World Health Organization showing that, in 2012, 
about 5.9% of all global deaths were attributable to alcohol consumption (World Health 
Organization). In this context, efforts have been made to better elucidate the mechanisms 
for the development of dependence and its whole spectrum of manifestations. AD is a 
complex phenotype, in which both environmental and genetic factors are involved in its 
etiology (Bau, 2002). Since its heritability estimates are around 50% (Verhulst et al., 2015), 
association studies have sought to identify genetic factors involved in its susceptibility. The 
most consistent results involve genes responsible for alcohol metabolism, such as the genes 
encoding alcohol dehydrogenase (ADH) (Ehlers et al., 2012; Gelerneter et al., 2014; 
Marshall et al., 2014; Park et al., 2013; Peng et al., 2014; Zuo et al., 2014) and aldehyde 
dehydrogenase (ALDH) (Ehlers et al., 2012; Gelerneter et al., 2014; Peng et al., 2014; Zuo 
et al., 2014). Additionally, genes involved in neurotransmission are considered to contribute 
to the etiology of alcoholism, especially those related to the dopaminergic pathway (Bau, 
2002; Contini et al., 2006; Mota et al., 2012; Wang et al., 2007).  
Neurotransmitters’ release (mostly epinephrine, serotonin and dopamine) on the 
reward-system pathways are related to the pathophysiology of addiction (Bear et al., 2007). 
Accordingly, alterations in the main components of neurotransmitter release such as 
Soluble NSF-Attachment Protein Receptors (SNARE) complex have already been 
implicated in several psychiatric disorders (reviewed in Cupertino et al., 2016) and could 
also be associated with AD susceptibility. The core components of the SNARE complex are 
Synaptosomal-Associated Protein of 25 kDa (SNAP-25), Syntaxin 1A (STX1A) and 
Vesicle-Associated Membrane Protein 2 (VAMP-2/Synaptobrevin-2). Neurotransmitter 
exocytosis also requires other accessory proteins, such as Synaptotagmin-1 (SYT1), located 
at the synaptic vesicle membrane.  
 Despite being important for several brain pathways, the SNARE complex has been 
poorly studied in relation to AD. In a study evaluating transcription levels of STX1A and 
VAMP2 in rats with alcohol-intake preference, mRNA levels of both genes were increased 
in frontal cortex in relation to the alcohol non-preferring rats (Worst et al., 2005). Linkage 
studies on alcohol use phenotypes have implicated regions in chromosome 7, containing 
STX1A (alcoholism - Strat et al., 2008) and chromosome 17, containing VAMP2 
(alcoholism - Hill et al., 2004; and alcohol consumption - Bergen et al., 2003). 
Furthermore, SNAP25 polymorphisms and haplotypes were shown to influence impulsivity 
traits of healthy adults (Németh et al., 2013). Taken together, these studies suggest that 
genetic variants within SNARE components might exert a role on alcoholism. In this 
context, the present study aims to evaluate polymorphisms in genes of the SNARE complex 
- STX1A (rs2228607 SNP), SYT1 (rs1880867 and rs2251214 SNPs), VAMP2 
(insertion/deletion polymorphism of 26 bp, referred to as 26 bp Ins/Del) and SNAP25 
(rs6108461 and rs8636 SNPs) - in relation to AD susceptibility in two independent 
samples. 
 
2. Material and Methods 
 
2.1. Subjects 
 
The cases sample comprised a total of 115 men (mean age 41.35 ± 10.18 years) 
meeting the DSM-III-R criteria for AD (Diagnostic and Statistical Manual of Mental 
Disorders, 3
th
 edition, revised version, APA, 1987), under an abstinence-controlled 
environment at Hospital Espírita de Porto Alegre, Brazil. Interviews were conducted based 
on the Semi-Structured Assessment for the Genetics in Alcoholism (SSAGA, Bucholz et 
al., 1994), developed by the Consortium on the Genetics of Alcoholism (COGA) of the US 
National Institute of Alcohol Abuse and Alcoholism.  
The control sample comprised 308 men (mean age 29.15 ± 8.54 years) assessed in 
the blood donation center at Hospital de Clínicas de Porto Alegre, Brazil, screened negative 
for Alcohol Dependence and Abuse through an adapted version of the Structured Clinical 
Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I; First et al., 1998).  
Additionally, a replication sample comprising 278 men who fulfilled DSM-IV 
criteria (APA, 1994) for Attention-Deficit/Hyperactivity Disorder (ADHD; mean age 32.42 
± 11.03 years) was ascertained in the ADHD Outpatient Clinic - Adult Division from 
Hospital de Clínicas de Porto Alegre, Brazil. These subjects were also evaluated for AD 
through SCID-I (First et al., 1998), totalizing 35 individuals with AD. The exclusion 
criteria were IQ score lower than 70, history of psychosis, presence of neurological disease, 
head traumas, and/or neurodegenerative disorders. The ADHD sample was used as a 
replication sample for nominal associations reported in the main case-control analyses. For 
further description of this sample see Grevet et al. (2006) and Vitola et al. (2012). 
The subjects included in the study were unrelated Brazilians of European descent, 
aged 18 years or older. Participants signed an informed consent form approved by the 
Ethics Committees of the corresponding institutions where volunteers were ascertained.  
 
2.2. Polymorphisms selection and laboratory methods 
 
 The polymorphisms were selected based on previous evidence of association with 
psychiatric disorders, description of SNP functionality or minor allele frequency higher 
than 10%. DNA was extracted from peripheral blood by salting out method (Lahiri and 
Nurnberger, 1991). The SXT1A, SYT1 and SNAP25 SNPs were genotyped by Real Time 
PCR using Taqman allelic discrimination assays (Applied Biosystems, Foster City, CA, 
USA); while VAMP2 26 bp Ins/Del was genotyped by PCR followed by 3.5% agarose 
electrophoresis gel. Genotype distributions were in Hardy-Weinberg equilibrium (p < 0.01). 
The genotyping rate was higher than 90%, and the genotyping error rate was lower than 
1%. Allelic and genotypic frequencies are shown in Supplementary Table S1.  
 
2.3. Statistical analyses 
 
 Case-control analyses were performed using binary logistic regression in SPSS 
software version 18.0 (IBM Corp, 2011). Age was included as covariate, since it was 
associated (p < 0.2) with both the outcome (AD) and some of the evaluated polymorphisms. 
In order to prevent type I error due to multiple tests, Bonferroni correction was applied 
considering 6 independent tests (number of evaluated polymorphism), changing the 
significance threshold to p < 0.05/6 = 0.008.  
Association findings were subsequently replicated in the ADHD sample, using also 
binary logistic regression with age as covariate. In order to better estimate the size effect of 
the results, a meta-analytic approach was performed comprising both findings (i.e. main 
and replication associations). Heterogeneity was evaluated through Cochrane’s Q statistic 
and I
2
 test. The appropriate meta-analytic model was chosen based on these results (i.e. 
fixed-model if PCochrane’s > 0.05; random-model if PCochrane’s < 0.05). These procedures were 
conducted using PLINK version 1.07 (Purcell et al., 2007).  
All tests were performed grouping genotypes according to their frequencies (i.e. 
heterozygotes and homozygotes for the minor allele were assembled and compared to 
homozygotes for the major allele). For the STX1A SNP (rs2228607), however, the 
homozygotes have similar frequencies and thus were grouped based on previous significant 
reports (i.e. AA+AG and GG).  
Haplotype analyses were performed for SYT1 (rs1880867-rs2251214) and SNAP25 
(rs6108461-rs8636) SNPs. Significant results were corrected under a 10,000-permutation 
[max(T)] procedure. The haplotype tests were conducted on PLINK software. 
 
3. Results 
 
The case-control analyses revealed that the Ins/Ins genotype of VAMP2 26 bp 
Ins/Del was associated with increased risk to AD (p = 0.012; OR = 2.21; Table 1). This 
result, however, did not remain significant after Bonferroni correction.  
The observed nominal association between VAMP2 26 bp Ins/Del and AD was 
subsequently replicated in the sample of patients with ADHD with and without comorbid 
AD. In this analysis, the Ins/Ins genotype of the VAMP2 26 bp Ins/Del was also associated 
with a higher frequency of AD (p = 0.008; OR = 5.26; Table 2).  
These results were compiled through a meta-analytic approach. After a literature 
search for other studies regarding this polymorphism and AD, no results were found. Thus, 
the meta-analysis was restricted to the present data. Since no significant heterogeneity was 
detected (PCochrane’s = 0.219; I
2 
= 33.69), a fixed-effect model was applied. Such meta-
analytic algorithm was used to obtain a better comprehension of the effect size of VAMP2 
26 bp Ins/Del, supporting the association of Ins/Ins genotype (p< 0.001; OR = 2.64) with an 
increased susceptibility to Alcohol Dependence (Supplementary Table S2).  
The haplotype analyses for SYT1 (rs1880867-rs2251214) and SNAP25 (rs6108461-
rs8636) SNPs did not reach significant thresholds (Pglobal = 0.155 and Pglobal = 0.102, 
respectively). 
 
 
4. Discussion 
 
 This study expands the association of the VAMP2 26 bp Ins/Del polymorphism, 
previously reported in ADHD (Kenar et al., 2014), to Alcohol Dependence. Additionally, 
this finding was replicated in a sample of patients with ADHD with or without AD. Our 
results reinforce the influence of SNARE complex genes in psychiatric disorders (reviewed 
in Cupertino et al., 2016).  
The 26 bp Ins/Del polymorphism is located at an intergenic region, at 2 kb from 3’ 
end of VAMP2 (Falbo et al., 2002), and has been investigated in a few studies. Concerning 
other neurological diseases and psychiatric disorders, this polymorphism was investigated 
in relation to Alzheimer Disease, where no association was found (Edgünlü et al., 2012), 
and to ADHD, where the Ins/Ins genotype was significantly more frequent in Turkish 
adults with ADHD compared to controls (Kenar et al., 2014). In the present study, we 
report a nominal association with AD as previously reported for ADHD. Despite being 
essential to scientific research (Anonymous, 2012; McNutt, 2014), replication has been a 
challenge in psychiatry studies (Kapur et al., 2012) mainly due to the expected small effect 
size and high heterogeneity observed in mental disorders. Thus, the replication within 
ADHD subjects reinforces the observed effect of VAMP2 26 bp Ins/Del on alcoholism. 
Since there is a small sample size and a wide range interval of Odds Ratio in the replication 
findings, the meta-analytic approach provided a more reliable effect size estimate, 
narrowing the confidence interval. Considering the overall scenario, it could be 
hypothesized that the association found in the Turkish sample might be due to subjacent 
endophenotype possibly related to both ADHD and AD susceptibilities.  
These findings support the relationship between ADHD and Alcohol Dependence, 
indicated by the high rates of this comorbidity (Ohlmeier et al., 2008; Young et al., 2015). 
The present results of an effect of 26 bp Ins/Del on alcoholism, taken together with its 
previous association reported with ADHD (Herken et al., 2014), corroborates the idea of 
shared genetic factors underlying psychiatric disorders (Arcos-Burgos et al., 2012), as well 
as neurobiological similarities in terms of neurotransmission, mainly through the reward 
system (Vendruscolo and Takahashi, 2011). 
 Some limitations of this study need to be considered. The sample size of case and 
controls groups, and especially of the ADHD replication sample, is relatively small and 
limited the statistical power. In this sense, the relative weak statistical power could possibly 
be related to the lack of association findings regarding other SNARE complex 
polymorphisms evaluated. The lack of functional studies on VAMP2 26 bp Ins/Del 
polymorphism limits the interpretation of our findings in terms of biological mechanisms. 
Finally, neuroimaging and other putative endophenotype analyses could disentangle the 
possible links between this genetic variation, ADHD and AD.  
As a conclusion, the current findings suggest that the VAMP2 26 bp Ins/Del should 
be considered in future genetic studies of AD. Additionally, the common factors underlying 
ADHD and AD must be included in the search for endophenotypes and susceptibility 
genetic factors.  
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Table 1. Case-control analyses of effects of SNARE complex gene variants on Alcohol Dependence 
susceptibility 
Gene – Polymorphism Genotype groups (n (%))   
  Reference Test OR (CI 95%) P-value 
STX1A - rs2228607 GG AA + AG   
 Cases (n=114) 23 (20.2) 91 (79.8) 0.96 (0.52-1.80) 0.903 
 Controls (n=305) 66 (21.6) 239 (78.4)   
SYT1 - rs1880867 TT GT + GG   
 Cases (n=115) 62 (53.9) 53 (46.1) 0.81 (0.49-1.34) 0.410 
 Controls (n=307) 140 (45.6) 167 (54.4)   
SYT1 - rs2251214 GG AA + AG   
 Cases (n=115) 69 (60.0) 46 (40.0) 0.69 (0.41-1.17) 0.166 
 Controls (n=306) 182 (59.5) 124 (40.5)   
VAMP2 – 26 bp Ins/Del Del/Del + Ins/Del  Ins/Ins   
 Cases (n=115) 21 (18.3) 94 (81.2) 2.21 (1.19-4.13) 0.012* 
 Controls (n-308) 89 (28.9) 219 (71.1)   
SNAP25 - rs6108461 GG AA + AG   
 Cases (n=115) 37 (32.2) 78 (67.8) 0.77 (0.45-1.33) 0.345 
 Controls (n=308) 83 (26.9) 225 (73.1)   
SNAP25 - rs8636 CC CT + TT   
 Cases (n=114) 44 (38.6) 70 (61.4) 1.09 (0.65-1.84) 0.735 
 Controls (n=306) 120 (39.2) 186 (60.8)   
SNARE complex genes evaluated included Syntaxin 1A (STX1A), Synaptotagmin (SYT1), Vesicle-Associated Membrane Protein 
(VAMP) and Synaptosomal-associated protein of 25kD (SNAP25). OR: Odds Ratio; CI: Confidence Interval. Age was used as 
covariate in case-control analysis.  
*P-value did not remain significant after Bonferroni correction (P<0.008). 
 
Table 2. Influence of VAMP2 26 bp Ins/Del on Alcohol Dependence susceptibility in 
individuals with ADHD  
Gene – Polymorphism Genotype groups (n (%))   
  Reference Test OR (CI 95%) P-value 
VAMP2 -26 bp Ins/Del Del/Del + Ins/Del  Ins/Ins   
 Cases (n=35) 3 (8.57) 32 (91.43) 5.26 (1.54-18.03) 0.008 
 Controls (n=243) 73 (30.04) 170 (69.96)   
 OR: Odds Ratio; CI: Confidence Interval. Age was used as covariate in case-control analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table S1. Allele and genotype frequencies of 
SNARE complex gene variants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STX1A, SYT1, VAMP2 and SNAP25: genes coding Syntaxin 1A, Synaptotagmin 
1, VAMP-2 and SNAP-25, respectively. Genotypic data are represented as n (%). 
 
 
 
 
 
 
 Alcohol (n = 115) Control (n= 308) 
STX1A – rs2228607    
G 49.1 % 49.7 % 
A  50.9 % 50.3 % 
GG 23 (20.2) 66 (21.6) 
AG 65 (57.0) 171 (56.1) 
AA 26 (22.8) 68 (22.3) 
SYT1 – rs1880867   
G 27.0 % 33.1 % 
T 73.0 % 66.9 % 
GG 8 (7.0) 36 (11.7) 
GT 45 (39.1) 131 (42.7) 
TT 62 (53.9) 140 (45.6) 
SYT1 – rs2251214   
A 22.6 % 23.5 % 
G 77.4 % 76.5 % 
AA 6 (5.2) 19 (6.2) 
AG 40 (34.8) 105 (34.3) 
GG 69 (60.0) 182 (59.5) 
VAMP2 – 26 bp Ins/Del   
Del 9.6 % 14.6 % 
Ins 90.4 % 85.4 % 
Del/Del 0 (0.0) 1 (0.3) 
Ins/Del 21(18.3) 88 (28.6) 
Ins/Ins 94 (81.7) 219 (71.1) 
SNAP25 – rs6108461   
A 44.3 % 46.1 % 
G 55.7 % 53.9 % 
AA 24 (20.9) 59 (19.2) 
AG 54 (47.0) 166 (53.9) 
GG 37 (32.1) 83 (26.9) 
SNAP25 – rs8636   
T 38.6 % 37.1 % 
C 61.4 % 62.9 % 
TT 18 (15.8) 41 (13.4) 
CT 52 (45.6) 145 (47.4) 
CC 44 (38.6) 120 (39.2) 
Supplementary Table S2. Meta-analysis of the association studies 
of VAMP2 26 bp Ins/Del in Alcohol Dependence 
Sample P-value OR
a
 (CI 95%) 
Genotype Group   
Discovery sample 0.012 2.21 (1.19-4.13) 
Replication sample 0.008 5.26 (1.54-18.03) 
Meta-analysis <0.001
b
 2.64 (1.51-4.60) 
CI: Confidence Interval. 
a 
Odds Ratio (OR) referred to Ins/Ins genotype. 
b
 PCochrane’s = 0.219; I
2
 = 33.69. 
